Jazz Pharmaceuticals SVP, Chief Accounting Officer Patricia Carr Reports $326,909.51 Share Disposal

• Jazz Pharmaceuticals SVP and Chief Accounting Officer Patricia Carr sold 1,413 ordinary shares on Nov. 4, 2026.
• Sales comprised 1,250 shares at $231.37 each and 163 shares at $231.27 each.
• Carr also exercised non-qualified stock options for 1,250 ordinary shares at $140.03 each that day.
• Following the transactions, she directly owned 6,512 ordinary shares and 3,000 non-qualified stock options.
• The Form 4 was signed Nov. 6, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001784606-26-000018), on November 06, 2026, and is solely responsible for the information contained therein.